Medical significance and management of staphylococcal biofilm

被引:69
作者
Agarwal, Astha [1 ]
Singh, Kaleshwar Prasad [1 ]
Jain, Amita [1 ]
机构
[1] Chhatrapati Shahuji Maharaj Med Univ, Dept Microbiol, Lucknow 226003, Uttar Pradesh, India
来源
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY | 2010年 / 58卷 / 02期
关键词
biofilm structure; formation; medical significance; management; POLYSACCHARIDE INTERCELLULAR ADHESIN; CATHETER-RELATED BACTEREMIA; EXPERIMENTAL BACTERIAL-ENDOCARDITIS; PROSPECTIVE RANDOMIZED-TRIAL; QUORUM-SENSING CONTROL; SAPROPHYTICUS HEMAGGLUTININ; ANTIMICROBIAL PEPTIDES; TRANSPOSON MUTANTS; POVIDONE-IODINE; BINDING-PROTEIN;
D O I
10.1111/j.1574-695X.2009.00601.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Biofilm is one of the important virulence factors of staphylococci that plays a role in many device-related infections such as native valve endocarditis, otitis media, urinary tract infections, cystic fibrosis, acute septic arthritis, etc. Biofilm is a microbially derived sessile community of microorganisms, developed either from single or multiple microorganisms. Formation of biofilm is a two-step process: adherence of cells to a surface and accumulation of cells to form multilayered cell clusters. A trademark of biofilm formation in staphylococci is the production of polysaccharide intercellular adhesin. In the formation and regulation of biofilm, some biosynthetic genes (icaADBC) and some regulatory genes (icaR, sar, agr, rbf, Sigma B) are involved. In this article, we reviewed the structure and formation of staphylococcal biofilm and its role in medical infections.
引用
收藏
页码:147 / 160
页数:14
相关论文
共 138 条
[1]
Adams JL, 1999, APPL ENVIRON MICROB, V65, P4285
[2]
CHILDHOOD BRUCELLOSIS - A STUDY OF 102 CASES [J].
ALEISSA, YA ;
KAMBAL, AM ;
ALNASSER, MN ;
ALHABIB, SA ;
ALFAWAZ, IM ;
ALZAMIL, FA .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1990, 9 (02) :74-79
[3]
An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO
[4]
2-B
[5]
ANTIMICROBIAL SUSCEPTIBILITY OF COAGULASE-NEGATIVE STAPHYLOCOCCI [J].
ARCHER, GL ;
CLIMO, MW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (10) :2231-2237
[6]
Ash Stephen R, 2000, Hemodial Int, V4, P22, DOI 10.1111/hdi.2000.4.1.22
[7]
Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents [J].
Baillie, GS ;
Douglas, LJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) :1900-1905
[8]
A novel in vitro model to study staphylococcal biofilm formation on intraocular lenses under hydrodynamic conditions [J].
Baillif, Stephanie ;
Casoli, Emmanuelle ;
Marion, Karine ;
Roques, Christine ;
Pellon, Gerard ;
Hartmann, Daniel Jean ;
Freney, Jean ;
Burillon, Carole ;
Kodjikian, Laurent .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (08) :3410-3416
[9]
Prevention of diseases caused by Staphylococcus aureus using the peptide RIP [J].
Balaban, N ;
Collins, LV ;
Cullor, JS ;
Hume, EB ;
Medina-Acosta, E ;
da Motta, OV ;
O'Callaghan, R ;
Rossitto, PV ;
Shirtliff, ME ;
da Silveira, LS ;
Tarkowski, A ;
Torres, JV .
PEPTIDES, 2000, 21 (09) :1301-1311
[10]
Prevention of Staphylococcal biofilm-associated infections by the quorum sensing inhibitor RIP [J].
Balaban, N ;
Stoodley, P ;
Fux, CA ;
Wilson, S ;
Costerton, JW ;
Dell'Acqua, G .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2005, (437) :48-54